Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.W | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Post by tuesdaynightridon Oct 05, 2015 12:10pm
202 Views
Post# 24163684

TLC-2000 Approval

TLC-2000 Approval
Just popped in to check status on TLC-2000 approval.

Even I expected RW to have an approval before the end of September 2015 given that he stated approval by September 2014 in his Korelin interview a year ago and in his 75 day proclamation in February 2015.

Now I read a few weeks back that the TLC-3000 has been renamed as the TLC-3200. Even better, the TLC-3200 is somehow a mandatory part of the Ph1 cancer trials.
It's amazing that RW did not even mention this requirement when he called for Ph1/2a fast track approval when he did his barrage of interviews in the spring of 2014.

Did any of you brain surgeons ever get an explanation for why the TLC-3200 was even needed to activate the PDC? Seems like this has all been done before with prior art with Laserpherin and Photofrin. Maybe the informed on this board might ask about this at the AGM meeting. Or maybe there won't be one. Anyone know the AGM date? I may have to show up to see bencro to verify if my image of him is correct.

Here's a message for new shareholders or those considering. Go back and listen to what the CEO said he would do vs. what he has done. I think that sums it up pretty well. Hey maybe RW and his wife won't collect their 300k per year this year due to poor performance.
Now, I can just imagine what stress his wife must be under as the CFO. I mean, counting all that income that is rolling in from the TLC-2000 approval has to be stressful don't ya think!

Check back soon!
 



 
Bullboard Posts